Velocity’s research site in Sioux City frequently conducts clinical trials for a broad range of investigational treatments. The studies at this site explore vaccines and medicines developed to treat migraines, diabetes, acne, depression, high cholesterol, and other conditions. Acquired by Velocity in 2022, this location was founded in originally in Dakota Dunes in 2005 and later moved as part of Meridian Clinical Research.
Located near several major highways and roads, the site is easily accessible to thousands of patients. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Sioux City team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.